Collectively, these findings demonstrate that GNB2 acts as a functional downstream effector of Snhg5, mediating its regulatory effects on proliferation, apoptosis resistance, and motility in highly metastatic CRC cells. This evidence concerns the gene GNB2 and colorectal carcinoma.